Mendus
IMMU | ST
Overview
Corporate Details
- ISIN(s):
- SE0005003654 (+1 more)
- LEI:
- 529900AFBGFR7ZB50J95
- Country:
- Sweden
- Address:
- Västra Trädgårdsgatan 15, 111 53 Stockholm
- Website:
- https://mendus.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Mendus is dedicated to changing the course of cancer treatment by addressing tumor recurrence and improving survival outcomes for cancer patients, while preserving quality of life. We are leveraging our unparalleled expertise in allogeneic dendritic cell biology to develop an advanced clinical pipeline of novel, off-the-shelf, cell-based immunotherapies which combine clinical efficacy with a benign safety profile. Based in Sweden and The Netherlands, Mendus is publicly traded on the Nasdaq Stockholm under the ticker IMMU.ST.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-26 17:50 |
Declaration of Voting Results & Voting Rights Announcements
Mendus AB (publ) har beslutat om emission av C-aktier och överlåtelse av egna s…
|
Swedish | 117.6 KB | |
| 2025-05-26 17:50 |
Transaction in Own Shares
Mendus AB (publ) has decided on directed issues of Class C shares and transfer …
|
English | 118.1 KB | |
| 2025-05-06 10:10 |
Regulatory News Service
Kommuniké från årsstämma i Mendus AB (publ) den 6 maj 2025
|
Swedish | 128.6 KB | |
| 2025-05-06 10:10 |
Regulatory News Service
Report from the Annual General Meeting of Mendus AB (publ) on 6 May 2025
|
English | 128.9 KB | |
| 2025-05-06 08:00 |
Earnings Release
|
Swedish | 1.4 MB | |
| 2025-05-06 08:00 |
Quarterly Report
|
English | 1.4 MB | |
| 2025-02-13 08:00 |
Earnings Release
|
Swedish | 1.5 MB | |
| 2025-02-13 08:00 |
Earnings Release
|
English | 1.5 MB | |
| 2024-08-23 08:00 |
Earnings Release
|
Swedish | 1.3 MB | |
| 2024-08-23 08:00 |
Earnings Release
|
English | 1.3 MB | |
| 2024-06-28 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Ändring av antalet aktier och röster i Mendus AB (publ)
|
Swedish | 68.7 KB | |
| 2024-06-28 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in Mendus AB (publ)
|
English | 87.9 KB | |
| 2024-05-28 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Sammanläggning av aktier i Mendus AB (publ)
|
Swedish | 82.0 KB | |
| 2024-05-28 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Reverse share split in Mendus AB (publ)
|
English | 105.7 KB | |
| 2024-05-17 11:30 |
Declaration of Voting Results & Voting Rights Announcements
Report from the Annual General Meeting of Mendus AB (publ) on 17 May 2024
|
English | 109.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-11 | Erik Manting | Other | Buy | 7,780 | 56,249.40 SEK |
| 2025-03-11 | Erik Manting | Other | Buy | 7,780 | 55,704.80 SEK |
| 2025-02-25 | Sven Arne Andreasson | Other | Buy | 25,000 | 198,750.00 SEK |
| 2024-04-02 | Erik Manting | Other | Other | 885,648 | 425,111.04 SEK |
| 2024-04-02 | Dharminder Chahal | Other | Other | 882,048 | 423,383.04 SEK |
| 2024-04-02 | Leopold Bertea | Other | Other | 267,858 | 128,571.84 SEK |
| 2022-10-25 | Sven Arne Andreasson | Other | Sell | 15,000 | 31,950.00 SEK |
| 2022-10-12 | Sven Arne Andreasson | Other | Sell | 10,000 | 18,800.00 SEK |
| 2022-05-20 | Erik Manting | Other | Buy | 37,059 | 86,347.47 SEK |
| 2022-05-19 | Ann-Charlotte Ferm | Other | Buy | 100,000 | 215,900.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ANIMALCARE GROUP PLC | United Kingdom | ANCR | |
|
Annexin Pharmaceuticals AB | Sweden | ANNX | |
|
Apontis Pharma AG | Germany | APPH | |
|
Aptahem AB | Sweden | APTA | |
|
Arctic Bioscience | Norway | ABS | |
|
ArcticZymes Technologies | Norway | AZT | |
|
argenx SE | Netherlands (Kingdom of the) | 1AE | |
|
ARIX BIOSCIENCE PLC | United Kingdom | ARIX | |
|
AroCell AB | Sweden | AROC | |
|
Arterra Bioscience | Italy | ABS |